Mainz Biomed B.V. Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Revenue	0.9	0.53	0.58	0.49	0.28
Revenue Growth (YoY)	69.00%	-8.22%	16.98%	75.40%	-
Cost of Revenue	0.39	0.35	0.4	0.37	0.34
Gross Profit	0.51	0.18	0.18	0.12	-0.06
Selling, General & Admin	17.56	21.61	9.42	0.48	0.61
Research & Development	9.59	5.02	0.48	0.31	0.25
Operating Expenses	27.15	26.63	9.9	0.8	0.86
Operating Income	-26.64	-26.44	-9.72	-0.67	-0.92
Interest Expense / Income	0.81	0.29	0.34	0.18	0.16
Other Expense / Income	-1.16	-0.35	1.63	-0.26	-0.12
Pretax Income	-26.3	-26.39	-11.69	-0.59	-0.96
Net Income	-26.3	-26.39	-11.69	-0.59	-0.96
Shares Outstanding (Basic)	16	14	7	6	6
Shares Outstanding (Diluted)	16	14	7	6	6
Shares Change	14.73%	96.33%	28.60%	-	-
EPS (Basic)	-1.62	-1.86	-1.62	-0.10	-0.17
EPS (Diluted)	-1.62	-1.86	-1.62	-0.10	-0.17
Free Cash Flow	-23.84	-15.43	-3.24	-0.48	-0.42
Free Cash Flow Per Share	-1.47	-1.09	-0.45	-0.09	-0.07
Gross Margin	56.91%	34.38%	30.77%	24.94%	-21.77%
Operating Margin	-2975.47%	-4990.60%	-1684.36%	-136.50%	-327.62%
Profit Margin	-2936.50%	-4979.90%	-2024.79%	-118.91%	-340.11%
Free Cash Flow Margin	-2662.00%	-2911.63%	-560.67%	-96.93%	-148.01%
EBITDA	-24.62	-25.72	-11.28	-0.35	-0.75
EBITDA Margin	-2749.34%	-4853.62%	-1953.93%	-70.92%	-265.52%
Depreciation & Amortization	0.87	0.38	0.07	0.06	0.05
EBIT	-25.49	-26.1	-11.35	-0.41	-0.8
EBIT Margin	-2846.09%	-4925.30%	-1966.05%	-83.17%	-284.37%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).